This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Hepatitis B, Chronic
and you are
over 18
years old
Phase
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

This multicenter, prospective, observational study will evaluate the use in clinical practice and the efficacy and safety of Pegasys (peginterferon alfa-2a) in Chinese participants with HBeAg negative chronic hepatitis B. Participants receiving Pegasys according to the local label will be followed for the duration of their treatment and for one year after cessation of treatment.

Provided treatments

  • Drug: Pegylated Interferon Alfa (Peginterferon Alfa)
Tris trial is registered with FDA with number: NCT01730508. The sponsor of the trial is Hoffmann-La Roche and it is looking for 978 volunteers for the current phase.
Official trial title:
A MULTICENTER, PROSPECTIVE, OBSERVATIONAL, NON-INTERVENTIONAL COHORT STUDY IN CHINESE SUBJECTS WITH HBeAg NEGATIVE CHRONIC HEPATITIS B (CHB) RECEIVING THERAPY WITH PEGINTERFERON ALFA